Abeona Therapeutics, Inc. (ABEO)
2.485
-1.68
(-40.41%)
USD |
NASDAQ |
Nov 09, 11:47
Abeona Therapeutics Market Cap : 142.21M for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 238.63M |
| November 05, 2026 | 223.75M |
| November 04, 2026 | 241.49M |
| November 03, 2026 | 243.21M |
| November 02, 2026 | 243.21M |
| October 30, 2026 | 248.93M |
| October 29, 2026 | 260.95M |
| October 28, 2026 | 260.38M |
| October 27, 2026 | 254.66M |
| October 26, 2026 | 246.64M |
| October 23, 2026 | 251.79M |
| October 22, 2026 | 255.80M |
| October 21, 2026 | 258.09M |
| October 20, 2026 | 263.24M |
| October 19, 2026 | 252.37M |
| October 16, 2026 | 253.51M |
| October 15, 2026 | 266.10M |
| October 14, 2026 | 249.50M |
| October 13, 2026 | 258.66M |
| October 12, 2026 | 280.41M |
| October 09, 2026 | 282.70M |
| October 08, 2026 | 283.84M |
| October 07, 2026 | 290.71M |
| October 06, 2026 | 286.70M |
| October 05, 2026 | 292.42M |
| Date | Value |
|---|---|
| October 02, 2026 | 287.85M |
| October 01, 2026 | 286.70M |
| September 30, 2026 | 300.44M |
| September 29, 2026 | 295.29M |
| September 28, 2026 | 302.72M |
| September 25, 2026 | 309.02M |
| September 24, 2026 | 310.74M |
| September 23, 2026 | 316.46M |
| September 22, 2026 | 333.05M |
| September 21, 2026 | 324.47M |
| September 18, 2026 | 318.75M |
| September 17, 2026 | 319.89M |
| September 16, 2026 | 307.30M |
| September 15, 2026 | 313.03M |
| September 14, 2026 | 310.74M |
| September 11, 2026 | 309.88M |
| September 10, 2026 | 313.60M |
| September 09, 2026 | 331.34M |
| September 08, 2026 | 334.77M |
| September 04, 2026 | 343.36M |
| September 03, 2026 | 339.35M |
| September 02, 2026 | 340.49M |
| September 01, 2026 | 342.21M |
| August 31, 2026 | 334.77M |
| August 28, 2026 | 338.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 1.646B |
| ACADIA Pharmaceuticals, Inc. | 3.687B |
| Alnylam Pharmaceuticals, Inc. | 20.82B |
| Anika Therapeutics, Inc. | 196.60M |
| Savara, Inc. | 1.017B |
Market Cap Related Metrics
| PS Ratio | 5.428 |
| Price to Book Value | 1.111 |
| Price | 2.485 |
| Earnings Yield | -45.17% |